• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平滑肌肌球蛋白轻链激酶 B1 通过直接磷酸化和激活 SIRT6 抑制泡沫细胞形成和动脉粥样硬化。

Smooth muscle liver kinase B1 inhibits foam cell formation and atherosclerosis via direct phosphorylation and activation of SIRT6.

机构信息

National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.

School of Life Science and Key Laboratory of the Ministry of Education for Experimental Teratology, Shandong University, Jinan, China.

出版信息

Cell Death Dis. 2023 Aug 22;14(8):542. doi: 10.1038/s41419-023-06054-x.

DOI:10.1038/s41419-023-06054-x
PMID:37607939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10444762/
Abstract

Foam cell formation is a hallmark of the early phase of atherosclerosis. Growing evidence has demonstrated that vascular smooth muscle cells (VSMCs) comprise a considerable proportion of foam cells. Liver kinase B1 (LKB1) plays a crucial part in cardiovascular diseases. However, the role of LKB1 in VSMC-derived foam cell formation and atherosclerosis remains unclear. To explore the effects of LKB1 on VSMC-derived foam cell formation and atherosclerosis, we generated smooth muscle-specific LKB1 knockout (LKB1) mice by crossbreeding LKB1 mice with SM22α-CreER mice. LKB1 expression decreased in plaque-loaded aortas and oxidized low-density lipoprotein (oxLDL)-treated VSMCs. Compared with controls, atherosclerosis development was exacerbated in LKB1 mice via the promotion of VSMC-derived foam cell formation. Conversely, LKB1 overexpression inhibited lipid uptake and foam cell formation in VSMCs. Mechanistically, LKB1 binds to SIRT6 and directly phosphorylates and activates it, thereby reducing lectin-like oxLDL receptor-1 (LOX-1) via SIRT6-dependent histone deacetylation. Finally, adeno-associated virus (AAV)-mediated LOX-1 deficiency in smooth muscle ameliorated atherosclerosis in LKB1 mice. Our findings suggest that LKB1 may modulate VSMC-derived foam cell formation and atherosclerosis via the phosphorylation and activation of SIRT6.

摘要

泡沫细胞的形成是动脉粥样硬化早期阶段的一个标志。越来越多的证据表明,血管平滑肌细胞(VSMCs)构成了相当一部分泡沫细胞。肝激酶 B1(LKB1)在心血管疾病中起着至关重要的作用。然而,LKB1 在 VSMC 衍生的泡沫细胞形成和动脉粥样硬化中的作用尚不清楚。为了探讨 LKB1 对 VSMC 衍生的泡沫细胞形成和动脉粥样硬化的影响,我们通过将 LKB1 小鼠与 SM22α-CreER 小鼠杂交,生成了平滑肌特异性 LKB1 敲除(LKB1)小鼠。斑块负荷的主动脉和氧化型低密度脂蛋白(oxLDL)处理的 VSMCs 中 LKB1 的表达降低。与对照组相比,LKB1 小鼠通过促进 VSMC 衍生的泡沫细胞形成,使动脉粥样硬化的发展加剧。相反,LKB1 的过表达抑制了 VSMCs 中的脂质摄取和泡沫细胞形成。机制上,LKB1 与 SIRT6 结合,并直接磷酸化和激活它,从而通过 SIRT6 依赖性组蛋白去乙酰化来减少凝集素样 oxLDL 受体-1(LOX-1)。最后,腺相关病毒(AAV)介导的平滑肌中 LOX-1 的缺失改善了 LKB1 小鼠的动脉粥样硬化。我们的研究结果表明,LKB1 可能通过 SIRT6 的磷酸化和激活来调节 VSMC 衍生的泡沫细胞形成和动脉粥样硬化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/af3ce79033fe/41419_2023_6054_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/ecaf8cb8f1f2/41419_2023_6054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/6caf77584a78/41419_2023_6054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/f66dfdf54aac/41419_2023_6054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/cf142919f259/41419_2023_6054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/5099e44dcf7d/41419_2023_6054_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/b4ee9a4ed901/41419_2023_6054_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/e0454014f8f9/41419_2023_6054_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/af3ce79033fe/41419_2023_6054_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/ecaf8cb8f1f2/41419_2023_6054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/6caf77584a78/41419_2023_6054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/f66dfdf54aac/41419_2023_6054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/cf142919f259/41419_2023_6054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/5099e44dcf7d/41419_2023_6054_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/b4ee9a4ed901/41419_2023_6054_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/e0454014f8f9/41419_2023_6054_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6dd/10444762/af3ce79033fe/41419_2023_6054_Fig8_HTML.jpg

相似文献

1
Smooth muscle liver kinase B1 inhibits foam cell formation and atherosclerosis via direct phosphorylation and activation of SIRT6.平滑肌肌球蛋白轻链激酶 B1 通过直接磷酸化和激活 SIRT6 抑制泡沫细胞形成和动脉粥样硬化。
Cell Death Dis. 2023 Aug 22;14(8):542. doi: 10.1038/s41419-023-06054-x.
2
The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis.P2RY12 受体通过抑制晚期动脉粥样硬化中的自噬促进血管平滑肌细胞源性泡沫细胞的形成。
Autophagy. 2021 Apr;17(4):980-1000. doi: 10.1080/15548627.2020.1741202. Epub 2020 Mar 19.
3
Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis.巨噬细胞肝激酶B1抑制泡沫细胞形成和动脉粥样硬化。
Circ Res. 2017 Oct 13;121(9):1047-1057. doi: 10.1161/CIRCRESAHA.117.311546. Epub 2017 Aug 21.
4
SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis.SIRT6 保护平滑肌细胞免于衰老并减少动脉粥样硬化。
Circ Res. 2021 Feb 19;128(4):474-491. doi: 10.1161/CIRCRESAHA.120.318353. Epub 2020 Dec 22.
5
Vascular smooth muscle cell c-Fos is critical for foam cell formation and atherosclerosis.血管平滑肌细胞 c-Fos 对于泡沫细胞形成和动脉粥样硬化至关重要。
Metabolism. 2022 Jul;132:155213. doi: 10.1016/j.metabol.2022.155213. Epub 2022 May 2.
6
Dickkopf-1 promotes vascular smooth muscle cell foam cell formation and atherosclerosis development through CYP4A11/SREBP2/ABCA1.Dickkopf-1 通过 CYP4A11/SREBP2/ABCA1 促进血管平滑肌细胞泡沫细胞形成和动脉粥样硬化发展。
FASEB J. 2023 Aug;37(8):e23048. doi: 10.1096/fj.202300295R.
7
Liver kinase B1 inhibits smooth muscle calcification via high mobility group box 1.肝激酶 B1 通过高迁移率族蛋白 1 抑制平滑肌钙化。
Redox Biol. 2021 Jan;38:101828. doi: 10.1016/j.redox.2020.101828. Epub 2020 Dec 6.
8
SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE mice.在载脂蛋白 E 敲除小鼠中,血管平滑肌细胞中 SCAP 的敲低通过上调自噬来减轻动脉粥样硬化斑块的形成。
FASEB J. 2019 Mar;33(3):3437-3450. doi: 10.1096/fj.201800975RRR. Epub 2018 Nov 21.
9
Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis.平滑肌 22α 蛋白通过支持正常 LXRα 信号转导,改善动脉粥样硬化,抑制 VSMC 泡沫细胞形成。
Cell Death Dis. 2021 Oct 22;12(11):982. doi: 10.1038/s41419-021-04239-w.
10
LKB1 delays atherosclerosis by inhibiting phenotypic transformation of vascular smooth muscle cells.LKB1 通过抑制血管平滑肌细胞的表型转化来延缓动脉粥样硬化。
Int J Cardiol. 2024 Jan 1;394:131363. doi: 10.1016/j.ijcard.2023.131363. Epub 2023 Sep 16.

引用本文的文献

1
Lipid infiltration promotes trans-differentiation of vascular smooth muscle cells into macrophage-like cells in early lesions of human coronary atherosclerosis.脂质浸润在人类冠状动脉粥样硬化早期病变中促进血管平滑肌细胞向巨噬细胞样细胞转分化。
Lipids Health Dis. 2025 Jul 14;24(1):239. doi: 10.1186/s12944-025-02662-y.
2
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis.血管平滑肌细胞:动脉粥样硬化的治疗靶点
Rev Cardiovasc Med. 2025 Jun 26;26(6):28240. doi: 10.31083/RCM28240. eCollection 2025 Jun.
3
Macrophage WEE1 Directly Binds to and Phosphorylates NF-κB p65 Subunit to Induce Inflammatory Response and Drive Atherosclerosis.

本文引用的文献

1
SIRT6 inhibits hypoxia-induced pulmonary arterial smooth muscle cells proliferation via HIF-1α/PDK4 signaling.SIRT6 通过 HIF-1α/PDK4 信号抑制低氧诱导的肺动脉平滑肌细胞增殖。
Life Sci. 2023 Jan 1;312:121192. doi: 10.1016/j.lfs.2022.121192. Epub 2022 Nov 14.
2
LKB1: An emerging therapeutic target for cardiovascular diseases.LKB1:心血管疾病治疗的新兴靶点。
Life Sci. 2022 Oct 1;306:120844. doi: 10.1016/j.lfs.2022.120844. Epub 2022 Jul 27.
3
Vascular smooth muscle cell c-Fos is critical for foam cell formation and atherosclerosis.
巨噬细胞WEE1直接结合并磷酸化核因子κB p65亚基以诱导炎症反应并促进动脉粥样硬化。
Adv Sci (Weinh). 2025 Jul;12(26):e2503192. doi: 10.1002/advs.202503192. Epub 2025 Apr 9.
4
Epigenetics-targeted drugs: current paradigms and future challenges.表观遗传学靶向药物:当前范例与未来挑战。
Signal Transduct Target Ther. 2024 Nov 26;9(1):332. doi: 10.1038/s41392-024-02039-0.
5
An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis.氧化低密度脂蛋白诱导动脉粥样硬化中血管平滑肌细胞源性泡沫细胞的研究进展
Front Cell Dev Biol. 2024 Oct 25;12:1481505. doi: 10.3389/fcell.2024.1481505. eCollection 2024.
6
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies.动脉粥样硬化中的NLRP3炎性小体:机制与靶向治疗
Front Pharmacol. 2024 Jul 31;15:1430236. doi: 10.3389/fphar.2024.1430236. eCollection 2024.
7
Navigating the Maze of Kinases: CaMK-like Family Protein Kinases and Their Role in Atherosclerosis.激酶迷宫导航:钙调蛋白样家族蛋白激酶及其在动脉粥样硬化中的作用。
Int J Mol Sci. 2024 Jun 5;25(11):6213. doi: 10.3390/ijms25116213.
血管平滑肌细胞 c-Fos 对于泡沫细胞形成和动脉粥样硬化至关重要。
Metabolism. 2022 Jul;132:155213. doi: 10.1016/j.metabol.2022.155213. Epub 2022 May 2.
4
Association of Sirtuin Gene Polymorphisms with Susceptibility to Coronary Artery Disease in a North Chinese Population.Sirtuin 基因多态性与中国北方人群冠心病易感性的关联。
Biomed Res Int. 2022 Feb 18;2022:4294008. doi: 10.1155/2022/4294008. eCollection 2022.
5
Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis.自噬在动脉粥样硬化过程中在白细胞和非白细胞泡沫细胞中受到不同调节。
Circ Res. 2022 Mar 18;130(6):831-847. doi: 10.1161/CIRCRESAHA.121.320047. Epub 2022 Feb 9.
6
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
7
The Role and Mechanism of SIRT6 in Regulating Phenotype Transformation of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm.SIRT6 在调节腹主动脉瘤血管平滑肌细胞表型转化中的作用和机制。
Comput Math Methods Med. 2022 Jan 6;2022:3200798. doi: 10.1155/2022/3200798. eCollection 2022.
8
SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease.SIRT6 通过 Runx2 保护血管平滑肌细胞免受慢性肾脏病中的成骨细胞转分化。
J Clin Invest. 2022 Jan 4;132(1). doi: 10.1172/JCI150051.
9
Decreased serum SIRT6 as a novel predictor of coronary artery disease.血清 SIRT6 降低可作为冠心病的新型预测指标。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6660-6669. doi: 10.26355/eurrev_202111_27110.
10
FAK Activation Promotes SMC Dedifferentiation via Increased DNA Methylation in Contractile Genes.FAK 激活通过增加收缩基因中的 DNA 甲基化促进 SMC 去分化。
Circ Res. 2021 Dec 3;129(12):e215-e233. doi: 10.1161/CIRCRESAHA.121.319066. Epub 2021 Oct 27.